461.25MMarket Cap-3981P/E (TTM)
6.590High6.130Low2.45MVolume6.200Open6.240Pre Close15.69MTurnover3.48%Turnover RatioLossP/E (Static)71.07MShares14.84052wk High3.02P/B457.88MFloat Cap2.09052wk Low--Dividend TTM70.55MShs Float978.000Historical High--Div YieldTTM7.37%Amplitude-1731.000Historical Low6.401Avg Price1Lot Size
Altimmune Stock Forum
Larger Image: tradingview.com...
$Altimmune (ALT.US)$
Altimmune Announces Publication of Clinical Study of Pemvidutide in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Journal of Hepatology
Altimmune (Nasdaq: ALT) has published data from a 12-week clinical trial of pemvidutide, a GLP-1/glucagon dual receptor agonist, in the Journal of Hepatology. The study focused on metabolic dysfunction-associated steatotic liver disease (MASLD). Key findings include:
- Up to 68.5% relative reduction in liver fat con...
Larger Image: tradingview.com...
$Altimmune (ALT.US)$
No comment yet